BBIO Stock Analysis: Buy, Sell, or Hold?
BBIO - BridgeBio Pharma, Inc. Common Stock
$80.09
-2.05 (-2.50%)
▼
5d:
-4.68%
30d:
+7.47%
90d:
+12.63%
BUY
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 04, 2026
1d
Smart Money Accumulation
None View Scanner →
Strength: 6.5/10
Get Alerted When BBIO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: BBIO shows positive signals but monitor for confirmation. Market pricing in 10.6% decline. Moderate conviction.
💡 BUY OPPORTUNITY: BBIO shows positive signals but monitor for confirmation. Market pricing in 10.6% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$19.92
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$12.37
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BBIO is currently trading at $80.09, which is considered fair relative to its 30-day fair value range of $73.36 to $84.91. From a valuation perspective, the stock is trading at a discount (Forward PE: 140.8) compared to its historical average (197.1). Remarkably, the market is currently pricing in an annual earnings decline of 10.6% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, BBIO is in a strong uptrend. The price is currently testing key support at $79.45. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $105.26 (+31.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, BBIO is in a strong uptrend. The price is currently testing key support at $79.45. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $105.26 (+31.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$73.36 -
$84.91
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
72.4%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 31.4% below Wall St target ($105.26)
Trading Range Analysis
30-Day Trading Range
$73.36 -
$84.91
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$79.46
Resistance Level
$86.32
Current Trend
Strong Uptrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
140.83
Wall Street Target
$105.26
(+31.4%)
Revenue Growth (YoY)
66.8%
Profit Margin
-124.4%
Valuation Discount vs History
-10.6% cheaper
PE vs Historical
140.8 vs 197.1
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-10.6%
(market-implied from PE analysis)
1-Year Target
$72.08
(-10%)
2-Year Target
$64.87
(-19%)
3-Year Target
$58.39
(-27%)
3-Yr Target (if PE normalizes)
(PE: 141→197)
$81.71
(+2%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 140.8 to 197.1
Stabilization Target:
$112.09
(+40.0%)
PE Expansion Potential:
+40.0%
Share & Embed Analysis
Last updated: August 02, 2026 6:33 PM ET
Data refreshes hourly during market hours. Next update: 7:33 PM
Data refreshes hourly during market hours. Next update: 7:33 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BBIO showing a specific setup today?
Insider Activity (6 Months)
3
Buys
8
Sells
Net
INSIDERS SELLING
Recent Transactions
Neil Kumar
SELL
40000 shares
2026-04-09
Gilbert Ray Cisneros, Jr.
BUY
2026-03-19
Gilbert Ray Cisneros, Jr.
BUY
2026-03-18
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$416 | 53 HOLD |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$386 | 43 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$89 | 59 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$557 | 49 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$309 | 54 HOLD |
Advanced BBIO Option Strategies
Professional options setups generated by AI based on today's BBIO price and gamma walls.
